Status:
UNKNOWN
Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions:
Fluorescence
Indocyanine Green
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
To investigate the accuracy of fluorescence angiography technique IMA classification and the impact of lymph node mapping technique on the dissection of No. 253 lymph nodes.
Detailed Description
Multiple studies, including randomized controlled trials (RCTs), have demonstrated that lymph node imaging techniques can effectively increase the number of harvested lymph nodes in gastric and colore...
Eligibility Criteria
Inclusion
- Patients aged between 18 and 75 years
- Colonoscopic biopsy confirmed colorectal adenocarcinoma
- The tumor was located in the rectum or upper rectum, and the surgical method was Dxion
- No local complications before operation (no obstruction, incomplete obstruction, no massive active bleeding, no perforation, abscess formation, no local invasion)
- Preoperative imaging diagnosis was cT1-4aNxM0
- The hematopoietic functions of heart, lung, liver, kidney and bone marrow meet the requirements of surgery and anesthesia
- Sign the informed consent form
Exclusion
- Previous surgical history of malignant colorectal tumors
- The surgical methods were combined abdominoperineal resection, Hartman operation and ISR operation
- There are contraindication of laparoscopic surgery, such as severe cardiopulmonary insufficiency
- Patients who have undergone multiple abdominal and pelvic surgeries or extensive abdominal adhesion
- Patients with intestinal obstruction, intestinal perforation, intestinal bleeding and other emergency operations
- ASA grade ≥IV and/or ECOG physical status score ≥2 points
- Patients with severe liver and kidney function, cardiopulmonary function, coagulation dysfunction or combined with serious underlying diseases can not tolerate surgery
- Have a history of serious mental illness
- Patients with uncontrolled infection before operation
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06033794
Start Date
May 1 2023
End Date
May 1 2024
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China, 100021